comparemela.com

Latest Breaking News On - Human immunology bioscience - Page 1 : comparemela.com

GlobalData : IGNAZ trial interim results highlight HI-Bio s potential to differentiate in IgAN space, says GlobalData

31 May, 2024 IGNAZ trial interim results highlight HI-Bio s potential to differentiate in IgAN space, says GlobalData Share .

Kajal jaddooEuropean renal associationHuman immunology bioscienceSenior pharma analyst

Biogen To Buy Human Immunology Biosciences In Deal Valued At Up To $1 8 Bln

WESTON (dpa-AFX) - Biogen Inc. (BIIB) and privately-held biotechnology company Human Immunology Biosciences or HI-Bio, announced Wednesday the companies have entered into a definitive agreement

Biogen incHuman immunology biosciencesHuman immunology bioscienceSan francisco bay areaIhr portfolio

Week In Review: Joincare Plans $300-$400 Million IPO On Swiss Exchange

Unofficial sources said Joincare would seek to raise around $300 to $400 million. Click here to read a weekly update on China biopharma companies.

New jerseyUnited statesUnited kingdomHong kong winhealth pharmaKangpu biopharmaTang ming tung digitalvisionClover biopharmaBioscience hibioTang mingRobo technologiesIts megalabGoldman sachs asset managementAsia investment capitalHuman immunology bioscienceGreater chinaShanghai henlius biotech

vimarsana © 2020. All Rights Reserved.